← Back to Search

Functional Assessment + X-Ray Imaging for Pelvic Sarcoma

N/A

Recruiting

Led By Valerae O Lewis

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who have received or are scheduled to receive an internal hemipelvectomy with or without reconstruction at UT MD Anderson Cancer Center

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial studies how to use patient-specific models to plan surgeries and rehabilitation treatments for people with pelvic sarcomas.

Who is the study for?

This trial is for adults who have or will undergo internal hemipelvectomy at UT MD Anderson Cancer Center to treat pelvic sarcomas. It's not for those with certain hip conditions, previous significant hip injuries/surgeries, recent surgeries affecting movement, pregnant/nursing women, or individuals with specific metal implants.Check my eligibility

What is being tested?

The study is developing personalized computational models to improve surgical planning and rehabilitation for better walking function after surgery in patients with pelvic sarcomas. It involves functional assessments and X-ray imaging to tailor treatment approaches.See study design

What are the potential side effects?

Since the trial focuses on assessment and imaging rather than medication or invasive treatments, traditional side effects are not a primary concern. However, there may be minimal risks associated with exposure to radiation from X-rays.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for or have had a surgery to remove part of my pelvis at UT MD Anderson.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To establish the patient-specific computational models to inform surgical decisions and design custom implants that maximize post-surgery function.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Supportive care (walking function test, X-ray)Experimental Treatment2 Interventions

Patients undergo walking function assessment using optical motion capture and bi-plane dynamic X-ray imaging pre- and post-hemipelvectomy.

Group II: Retrospective GroupActive Control1 Intervention

Acquisition of pre- and post-operative MRI data of the pelvic region (when available) collected previously as part of standard clinical care Acquisition of pre-operative CT data of the pelvic region (when available) collected previously as part of standard clinical care Acquisition of Physical Therapy Assessment data collected previously by a physical therapist and/or physical therapist assistant under protocol PA12-1046

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,660 Previous Clinical Trials

40,924,142 Total Patients Enrolled

M.D. Anderson Cancer CenterLead Sponsor

2,972 Previous Clinical Trials

1,787,169 Total Patients Enrolled

Valerae O LewisPrincipal InvestigatorM.D. Anderson Cancer Center

3 Previous Clinical Trials

325 Total Patients Enrolled

Media Library

Functional Assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05054335 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings available for individuals to join this research experiment?

"According to the clinicaltrials.gov, this trial is currently enrolling participants with a date of origin on June 20th 2019 and most recent update taking place in September 27 2022."

Answered by AI

What is the current enrolment count for this experiment?

"Affirmative. According to the information provided on clinicaltrials.gov, this trial is actively enrolling patients with an original post date of June 20th 2019 and a recent edit date of September 27th 2022. The research requires 130 participants from one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas

2019. "Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05054335.